Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Drug resistant tuberculosis: is it enough to justify low treatment success in Russia? Source: Eur Respir J 2001; 18: Suppl. 33, 175s Year: 2001
Drug resistance pattern of mycobacterium tuberculosis complex at the main reference tuberculosis centre in Greece, 2000-2010 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006
Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey Source: Eur Respir J, 51 (3) 1702571; 10.1183/13993003.02571-2017 Year: 2018
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Drug resistance to tuberculosis in Karachi Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
Drug resistant TB treatment outcomes in Novokuznetsk Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
Drug resistance in pulmonary tuberculosis in Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Drug resistant tuberculosis among Greek and immigrant patients in a pulmonary department in northern Greece Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Outcomes of MDR cases in Iasi county, Romania Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Drug susceptibility of mycobacterium tuberculosis isolates in Serbia over four-year period (2001–2004) Source: Eur Respir J 2006; 28: Suppl. 50, 857s Year: 2006
Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Changes in treatment for multidrug-resistant tuberculosis according to national income Source: Eur Respir J, 56 (5) 2001394; 10.1183/13993003.01394-2020 Year: 2020
Trends in antituberculous drug resistance pattern between 1990 and 2000 in a tuberculous reference hospital in Turkey Source: Eur Respir J 2002; 20: Suppl. 38, 403s Year: 2002
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003
Drug resistance and tuberculosis elimination in low-incidence countries Source: Eur Respir J 2014; 44: 1408-1411 Year: 2014
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002